Omeprazole Blocks STAT6 Binding to the Eotaxin-3 Promoter in Eosinophilic Esophagitis Cells

被引:145
|
作者
Zhang, Xi [1 ,2 ]
Cheng, Edaire [2 ,4 ]
Huo, Xiaofang [1 ,2 ]
Yu, Chunhua [1 ,2 ]
Zhang, Qiuyang [1 ,2 ]
Pham, Thai H. [2 ,3 ]
Wang, David H. [1 ,2 ,5 ]
Spechler, Stuart J. [1 ,2 ]
Souza, Rhonda F. [1 ,2 ,5 ]
机构
[1] Vet Affairs N Texas Hlth Care Syst, Dept Internal Med, Dallas, TX 75216 USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Vet Affairs N Texas Hlth Care Syst, Dept Surg, Dallas, TX USA
[4] Childrens Med Ctr, Dept Pediat, Dallas, TX 75235 USA
[5] Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA
来源
PLOS ONE | 2012年 / 7卷 / 11期
基金
美国国家卫生研究院;
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; GENE-EXPRESSION; CONSENSUS RECOMMENDATIONS; EPITHELIAL-CELLS; ACTIVATION; ACIDIFICATION; ASSOCIATION; CHILDREN; ATPASE; ADULTS;
D O I
10.1371/journal.pone.0050037
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Patients who have esophageal eosinophilia without gastroesophageal reflux disease (GERD) nevertheless can respond to proton pump inhibitors (PPIs), which can have anti-inflammatory actions independent of effects on gastric acid secretion. In esophageal cell cultures, omeprazole has been reported to inhibit Th2 cytokine-stimulated expression of eotaxin-3, an eosinophil chemoattractant contributing to esophageal eosinophilia in eosinophilic esophagitis (EoE). The objective of this study was to elucidate molecular mechanisms underlying PPI inhibition of IL-4-stimulated eotaxin-3 production by esophageal cells. Methods/Findings: Telomerase-immortalized and primary cultures of esophageal squamous cells from EoE patients were treated with IL-4 in the presence or absence of acid-activated omeprazole or lansoprazole. We measured eotaxin-3 protein secretion by ELISA, mRNA expression by PCR, STAT6 phosphorylation and nuclear translocation by Western blotting, eotaxin-3 promoter activation by an exogenous reporter construct, and STAT6, RNA polymerase II, and trimethylated H3K4 binding to the endogenous eotaxin-3 promoter by ChIP assay. Omeprazole in concentrations >= 5 mu M significantly decreased IL-4-stimulated eotaxin-3 protein secretion and mRNA expression. Lansoprazole also blocked eotaxin-3 protein secretion. Omeprazole had no effect on eotaxin-3 mRNA stability or on STAT6 phosphorylation and STAT6 nuclear translocation. Rather, omeprazole blocked binding of IL-4-stimulated STAT6, RNA polymerase II, and trimethylated H3K4 to the eotaxin-3 promoter. Conclusions/Significance: PPIs, in concentrations achieved in blood with conventional dosing, significantly inhibit IL-4-stimulated eotaxin-3 expression in EoE esophageal cells and block STAT6 binding to the promoter. These findings elucidate molecular mechanisms whereby patients with Th2 cytokine-driven esophageal eosinophilia can respond to PPIs, independent of effects on gastric acid secretion.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Major Basic Protein, Eotaxin-3, and Mast Cell Tryptase Staining for Diagnosis of Eosinophilic Esophagitis: A Prospective Study
    Dellon, Evan S.
    Speck, Olga
    Woodward, Kimberly
    Covey, Shannon
    Rusin, Spencer
    Gebhart, Jessica H.
    Chen, Xiaoxin L.
    Woosley, John T.
    Shaheen, Nicholas J.
    GASTROENTEROLOGY, 2014, 146 (05) : S664 - S664
  • [22] Practical utility of mucosal eotaxin-3 mRNA expression levels in diagnostically challenging cases of reflux/eosinophilic esophagitis
    Bhattacharya, B.
    Goldsmith, J.
    Meitner, P.
    Saba, E.
    Mangray, S.
    Treaba, D.
    Resnick, M.
    MODERN PATHOLOGY, 2008, 21 : 113A - 113A
  • [23] Fibroblast Growth Factor as an Improved Disease Indicator for Eosinophilic Esophagitis Compared with Eotaxin-3 and IL-5
    Huang, J. J.
    Nguyen, T.
    Nadeau, K. C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB162 - AB162
  • [24] Practical utility of mucosal eotaxin-3 mRNA expression levels in diagnostically challenging cases of reflux/eosinophilic esophagitis
    Bhattacharya, B.
    Goldsmith, J.
    Meitner, P.
    Sabo, E.
    Mangray, S.
    Treaba, D.
    Resnick, M.
    LABORATORY INVESTIGATION, 2008, 88 : 113A - 113A
  • [25] Interplay of adaptive Th2 immunity with eotaxin-3/C-C chemokine receptor 3 in eosinophilic esophagitis
    Bullock, Jennifer Z.
    Villanueva, Joyce M.
    Blanchard, Carine
    Filipovich, Alexandra H.
    Putnam, Philip E.
    Collins, Margaret H.
    Risma, Kimberly A.
    Akers, Rachel M.
    Kirby, Cassie L.
    Buckmeier, Bridget K.
    Assa'ad, Amal H.
    Hogan, Simon P.
    Rothenberg, Marc E.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 45 (01): : 22 - 31
  • [26] A STAT6 Inhibitor (AS1517499) and a Tyrosine Kinase Inhibitor (Leflunomide) Block IL-13/STAT6 Signaling and Eotaxin-3 Expression in Esophageal Fibroblasts and Epithelial Cells: Promising Agents to Improve Inflammation and Prevent Fibrostenosis in EoE
    Cheng, Edaire
    Zhang, Xi
    Huo, Xiaofang
    Yu, Chunhua
    Zhang, Qiuyang
    Nadatani, Yuji
    Tamagawa, Yuji
    Ding, Peiguo
    Wang, David H.
    Pham, Thai H.
    Dunbar, Kerry B.
    Spechler, Stuart J.
    Souza, Rhonda F.
    GASTROENTEROLOGY, 2015, 148 (04) : S51 - S52
  • [27] Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis
    Soria-Chacartegui, Paula
    Navares-Gomez, Marcos
    Molina-Jimenez, Francisca
    Laserna-Mendieta, Emilio J.
    Arias-Gonzalez, Laura
    Majano, Pedro
    Casabona, Sergio
    Lucendo, Alfredo J.
    Abad-Santos, Francisco
    Santander, Cecilio
    Zubiaur, Pablo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [28] Ruxolitinib, a Selective JAK1/2 Inhibitor, Blocks IL-13/STAT6 Signaling and Eotaxin-3 Expression in Esophageal Epithelial Cells and Fibroblasts: A Potential Agent to Treat Inflammation and Fibrosis in EoE
    Zhang, Xi
    Wang, David H.
    Huo, Xiaofang
    Yu, Chunhua
    Zhang, Qiuyang
    Tamagawa, Yuji
    Ding, Peiguo
    Thai Pham
    Dunbar, Kerry B.
    Spechler, Stuart J.
    Souza, Rhonda F.
    Cheng, Edaire
    GASTROENTEROLOGY, 2016, 150 (04) : S18 - S18
  • [29] An IgE-associated polymorphism in STAT6 alters NF-κB binding, STAT6 promoter activity, and mRNA expression
    Schedel, Michaela
    Frei, Remo
    Bieli, Christian
    Cameron, Lisa
    Adamski, Jerzy
    Lauener, Roger
    Kabesch, Michael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (03) : 583 - U282
  • [30] Gene silencing with STAT6 specific siRNAs blocks eotaxin release in IL-4/TNFα stimulated human epithelial cells
    Rippmann, JF
    Schnapp, A
    Weith, A
    Hobbie, S
    FEBS LETTERS, 2005, 579 (01): : 173 - 178